Understanding how joint damage progresses after ACL injuries
Genomic and Imaging Markers to Understand and Predict Progression of Joint Damage After Injury
This study is looking at how certain markers in your body can help predict how your knee might change after an ACL injury, and it's for people aged 18 to 40 who want to understand their recovery better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10899433 on NIH RePORTER |
What this research studies
This research investigates the biological and imaging markers that can help predict the progression of joint damage following an anterior cruciate ligament (ACL) injury. By analyzing synovial fluid and extracellular vesicles from patients aged 18 to 40, the study aims to identify how the body's response to the injury can indicate future joint degradation. The approach includes measuring soluble biomarkers and utilizing advanced imaging techniques to assess changes over time. This comprehensive assessment could lead to better predictions of post-injury outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are physically active individuals aged 18 to 40 who have recently suffered an ACL injury.
Not a fit: Patients who have not experienced an ACL injury or those over the age of 40 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide insights that help prevent or mitigate posttraumatic osteoarthritis in patients with ACL injuries.
How similar studies have performed: Previous research has shown promise in using biological markers to predict joint damage, but this specific approach is relatively novel.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Kirsch, Thorsten — New York University School of Medicine
- Study coordinator: Kirsch, Thorsten
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.